Abstract
In the scope of a research program aiming at the synthesis and pharmacological evaluation of new antithrombotic agents via rational molecular design, we describe in this paper the synthesis of benzyl ethers of aryl-pyrazolic oxime derivatives. Ethers' (2a–2c) and (3a–3c) are derived from 4-formyl-l-N-phenylpyrazole (4), in good yield. Designed as interphenylenic analogues of the ridogrel (1), one expects these compounds to present dual properties, i.e., thromboxane A2 receptors antagonism and thromboxane synthetase inhibition.
Notes
Purchased from Aldrich Co., Milwaukee, Wiscosin, USA.
Prepared in 70% yield for two steps, from methyl 4-hydroxymethyl benzoate21, by reaction with thionyl chloride in dry benzene followed treatment of the benzyl chloride derivative with potassium iodide in THF containing a catalytic amount of 18-crown-6.
ref. 19, p. 566.